Literature DB >> 24518527

Carfilzomib-related acute kidney injury.

Kenar D Jhaveri1, Shailaja Chidella1, Jeny Varghese2, Lionel Mailloux1, Craig Devoe3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24518527

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  10 in total

1.  Carfilzomib-induced nephrotoxcity.

Authors:  Kenar D Jhaveri; Rimda Wanchoo
Journal:  Kidney Int       Date:  2015-07       Impact factor: 10.612

2.  The Authors Reply.

Authors:  Mark A Perazella; Hassan Izzedine
Journal:  Kidney Int       Date:  2015-07       Impact factor: 10.612

Review 3.  Management of nephrotoxicity of chemotherapy and targeted agents: 2020.

Authors:  Varsha Chiruvella; Pavan Annamaraju; Achuta K Guddati
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer.

Authors:  Cristina Gutierrez; Colleen McEvoy; Laveena Munshi; R Scott Stephens; Michael E Detsky; Joseph L Nates; Stephen M Pastores
Journal:  Crit Care Med       Date:  2020-01       Impact factor: 7.598

Review 5.  Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.

Authors:  Rimda Wanchoo; Ala Abudayyeh; Mona Doshi; Amaka Edeani; Ilya G Glezerman; Divya Monga; Mitchell Rosner; Kenar D Jhaveri
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-21       Impact factor: 8.237

6.  Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the "real world".

Authors:  Hira S Mian; Mark A Fiala; Larysa Sanchez; Ravi Vij; Tanya M Wildes
Journal:  Ann Hematol       Date:  2021-01-21       Impact factor: 3.673

7.  Acute Tubular Necrosis in a Patient With Myeloma Treated With Carfilzomib.

Authors:  Vladimir Liberman; Vivette D D'Agati; Naveed N Masani; James Drakakis; Joseph Mattana
Journal:  Kidney Int Rep       Date:  2016-06-23

8.  Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report.

Authors:  Clarissa A Cassol; Michael P A Williams; Tiffany N Caza; Sophia Rodriguez
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 9.  Thrombotic microangiopathy associated with proteasome inhibitors.

Authors:  Ahad Lodhi; Abhishek Kumar; Muhammad U Saqlain; Manish Suneja
Journal:  Clin Kidney J       Date:  2015-07-16

10.  Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.

Authors:  Despina Fotiou; Maria Roussou; Charikleia Gakiopoulou; Erasmia Psimenou; Maria Gavriatopoulou; Magdalini Migkou; Nikolaos Kanellias; Ioanna Dialoupi; Evangelos Eleutherakis-Papaiakovou; Stavroula Giannouli; Christina Delavinia; Kostantinos Efstathiou; Sofoklis Kontogiannis; Evangelos Terpos; Meletios A Dimopoulos; Efstathios Kastritis
Journal:  Blood Cancer J       Date:  2020-11-03       Impact factor: 11.037
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.